The Latest Generation of Fraxel Technology Arrives at Medica in Saudi Arabia
Medica Clinics continues to develop its dermatology and laser technology portfolio by introducing Fraxel FTX, the latest generation of Fraxel technology for skin rejuvenation and the laser treatment of various skin concerns. This comes as an extension of Medica’s experience with previous generations of Fraxel and their use in treating a wide range of dermatological concerns.
The introduction of Fraxel FTX in Saudi Arabia is part of Medica’s commitment to keeping pace with the latest developments in aesthetic laser medicine, with a focus on technologies that provide physicians with greater precision in selecting settings and customizing treatments based on the nature of the skin and the specific concern being treated.
The new generation of Fraxel technology has enhanced the treatment experience in terms of handpiece motion tracking accuracy and ease of treatment customization, in addition to improvements in the system’s design and patient comfort during the session, while maintaining the dual-wavelength technology for which previous generations of Fraxel have been known.
What Is New in Fraxel FTX?
Fraxel FTX is based on non-ablative fractional laser technology, which treats precise microscopic areas of the skin without damaging the surrounding tissue. This mechanism helps stimulate the skin’s natural renewal processes while allowing the physician to control the depth and density of treatment according to each individual case.
The technology operates at two wavelengths: 1550 nm and 1927 nm. The 1550 nm wavelength reaches deeper levels of the skin, while the 1927 nm wavelength is designed to target more superficial layers of the skin. This provides physicians with greater flexibility and the ability to develop a treatment plan tailored to each individual case.
The advancement of Fraxel FTX does not lie in the laser power itself, but rather in the development of how the treatment is delivered and controlled. The technology is equipped with the AccuTRAC™ optical tracking system, designed to help deliver microscopic treatment zones consistently and evenly as the handpiece moves across the skin. The system also allows the physician to adjust the energy, treatment level, and number of passes according to the treatment area and the condition being addressed.
The new generation also includes a direct skin-cooling system designed to help improve patient comfort during the session. In addition, the handpiece has been redesigned to be lighter in weight and 20% smaller in circumference compared with the previous design, supporting easier use across different treatment areas.
What Conditions Can Be Treated With Fraxel FTX?
Fraxel FTX can be used to treat a number of superficial and deeper skin concerns, including:
- Fine lines and wrinkles.
- Dark spots and signs of sun damage.
- Skin rejuvenation, improved radiance, and stimulation of collagen production.
- Freckles and age spots.
- Pigmentation concerns and uneven skin tone.
- Acne scars.
- Surgical scars and burn scars.
- Certain cases of actinic keratosis, based on medical evaluation.
The choice of wavelength and treatment settings varies depending on the concern, its depth, the patient’s skin type, and the area being treated. Therefore, the treatment does not rely on one standardized setting for all patients. Instead, it is based on the physician’s evaluation and the development of an appropriate treatment plan for each individual.
From Fraxel Restore to Fraxel FTX: Medica’s Experience Across Generations of the Technology
The addition of Fraxel FTX does not mark the beginning of Medica’s experience with Fraxel technology. Rather, it represents the continuation of a long journey with its previous generations.
Since its establishment, Medica Clinics has been committed to being among the early adopters of the latest international technologies in aesthetic medicine, particularly technologies that have contributed to major advances in skin rejuvenation and aesthetic treatments. From this perspective, Fraxel technologies have been part of Medica’s technology portfolio for many years, and today the clinics continue this journey with the latest generation, Fraxel FTX.
Medica has used Fraxel Restore since 2008, before later transitioning to Fraxel Dual, which introduced the ability to work with two different wavelengths, expanding the range of skin depths and concerns that could be targeted.
Today, Medica continues this journey with Fraxel FTX as the latest generation within the Fraxel portfolio, benefiting from the accumulated experience gained from working with the technology across its different generations, as well as the new developments offered by the device in tracking precision, treatment customization, cooling, and ease of use.
Fraxel technology is backed by more than 20 years of innovation, with more than 1.5 million treatments performed and more than 90 clinical studies associated with the technology. This makes Fraxel FTX an extension of a technology that has evolved over more than two decades, during which it has demonstrated its ability to effectively and safely treat a wide range of skin concerns.
Fraxel FTX Is Now Available at Medica Clinics
The introduction of Fraxel FTX at Medica Clinics is an extension of its approach to adopting the latest generations of internationally recognized dermatology and laser technologies, while maintaining an element that is no less important than the advancement of the technology itself: the physician’s experience in using and managing the technology.
Fraxel technology relies heavily on accurate assessment and the selection of appropriate settings based on the patient’s skin type, the nature and depth of the concern, and the area being treated. While the technology, when used for the appropriate patient and according to a carefully planned treatment protocol, can contribute to the treatment of pigmentation concerns, sun damage, scars, and improvements in skin texture, inappropriate use resulting from insufficient experience or the selection of treatment settings that are unsuitable for the patient may increase the likelihood of side effects such as burns or pigmentation changes. These are among the recognized potential complications associated with laser treatments in general.
This is where accumulated experience in working with the technology becomes important—not merely its availability. At Medica, Fraxel FTX represents an extension of long-standing experience with the Fraxel platform across its different generations. This experience helps physicians understand the technology, customize treatments, and select the appropriate settings for each individual case while taking into consideration safety factors and the results we aim to achieve.
Accordingly, the arrival of the new generation is not simply the addition of a newer device to the clinics. Rather, it represents the continuation of extensive clinical experience with Fraxel technology and its developments over the years.
